Taking Ozempic or Mounjaro? Studies show that up to 40% of weight lost on GLP-1 drugs can be lean muscle mass. Here’s why that matters, what you can do about it, and the supplements that help protect your body composition.

Retatrutide is the new triple-agonist weight loss drug from Eli Lilly that showed an average 28.7% body weight loss in Phase 3 trials — outperforming Ozempic and Mounjaro. It’s not yet available in the UK, but here’s everything you need to know, plus the supplements that support any weight loss journey.